<VariationArchive VariationID="1452634" VariationName="NM_017780.4(CHD7):c.5665+1dup" VariationType="Duplication" Accession="VCV001452634" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-02" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1364353" VariationID="1452634">
      <GeneList>
        <Gene Symbol="CHD7" FullName="chromodomain helicase DNA binding protein 7" GeneID="55636" HGNC_ID="HGNC:20626" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60678740" stop="60868028" display_start="60678740" display_stop="60868028" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="61591323" stop="61780586" display_start="61591323" display_stop="61780586" Strand="+" />
          </Location>
          <OMIM>608892</OMIM>
          <Haploinsufficiency last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD7">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD7">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_017780.4(CHD7):c.5665+1dup</Name>
      <CanonicalSPDI>NC_000008.11:60851318:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60851318" stop="60851319" display_start="60851318" display_stop="60851319" variantLength="1" positionVCF="60851318" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="61763877" stop="61763878" display_start="61763877" display_stop="61763878" variantLength="1" positionVCF="61763877" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.61763879dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.61763879dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.60851320dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.60851320dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007009.1" sequenceAccession="NG_007009" sequenceVersion="1" change="g.177541dup">
            <Expression>NG_007009.1:g.177541dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017780.4" sequenceAccession="NM_017780" sequenceVersion="4" change="c.5665+1dup" MANESelect="true">
            <Expression>NM_017780.4:c.5665+1dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316690.1" sequenceAccession="NM_001316690" sequenceVersion="1" change="c.1717-10909dup">
            <Expression>NM_001316690.1:c.1717-10909dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_176" sequenceAccession="LRG_176">
            <Expression>LRG_176:g.177541dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2150806303" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017780.4(CHD7):c.5665+1dup AND CHARGE syndrome" Accession="RCV001994602" Version="3">
        <ClassifiedConditionList TraitSetID="513">
          <ClassifiedCondition DB="MedGen" ID="C0265354">CHARGE syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22461308</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25077900</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="513" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="886" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hittner Hirsch Kreh syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARGE ASSOCIATION--COLOBOMA, HEART ANOMALY, CHOANAL ATRESIA, RETARDATION, GENITAL AND EAR ANOMALIES</ElementValue>
                <XRef Type="MIM" ID="214800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">CHARGE syndrome</ElementValue>
                <XRef ID="MONDO:0008965" DB="MONDO" />
                <XRef ID="47535005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coloboma, heart anomaly, choanal atresia, retardation, genital and ear anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARGE association</ElementValue>
                <XRef ID="47535005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hall-Hittner syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHARGE</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CHD7 disorder encompasses the entire phenotypic spectrum of heterozygous CHD7 pathogenic variants that includes CHARGE syndrome as well as subsets of features that comprise the CHARGE syndrome phenotype. The mnemonic CHARGE syndrome, introduced in the premolecular era, stands for coloboma, heart defect, choanal atresia, retarded growth and development, genital hypoplasia, ear anomalies (including deafness). Following the identification of the genetic cause of CHD7 disorder, the phenotypic spectrum expanded to include cranial nerve anomalies, vestibular defects, cleft lip and/or palate, hypothyroidism, tracheoesophageal anomalies, brain anomalies, seizures, and renal anomalies. Life expectancy highly depends on the severity of manifestations; mortality can be high in the first few years when severe birth defects (particularly complex heart defects) are present and often complicated by airway and feeding issues. In childhood, adolescence, and adulthood, decreased life expectancy is likely related to a combination of residual heart defects, infections, aspiration or choking, respiratory issues including obstructive and central apnea, and possibly seizures. Despite these complications, the life expectancy for many individuals can be normal.</Attribute>
                <XRef ID="NBK1117" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="29" />
                <XRef ID="29" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301296</ID>
                <ID Source="BookShelf">NBK1117</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21407266</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="138" DB="Orphanet" />
              <XRef ID="C0265354" DB="MedGen" />
              <XRef ID="MONDO:0008965" DB="MONDO" />
              <XRef Type="MIM" ID="214800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4248316" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="14620333|MedGen:C0265354" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002235475" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22461308</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25077900</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Disruption of this splice site has been observed in individual(s) with clinical features of CHARGE syndrome (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change affects a splice site in intron 28 of the CHD7 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CHD7 are known to be pathogenic (PMID: 22461308, 25077900).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHD7" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.61763877_61763878insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265354" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4248316" TraitType="Disease" MappingType="XRef" MappingValue="C0265354" MappingRef="MedGen">
        <MedGen CUI="C0265354" Name="CHARGE syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

